IGFBP2 and Alzheimer disease: Furthermore, our finding that IGFBP-2 levels correlate with t-tau and p-tau in the CSF across the AD spectrum at baseline (Table 2) are in agreement with prior studies (Hertze et al., 2014; Åberg et al., 2015).